Pharmaceutical Attorneys Dangerous Drugs Defective Medical Devices Medical Conditions Currently Accepted Cases Our Lawyers Do I Have a Case? Contact Us

Bodybuilding.com Pays $7 million Fine for Food and Drug Act Violations

Bodybuilding.com, an online fitness supplement company, has agreed to pay $7 million in fines for violations of the federal Food and Drug Act. The company and its former president, Jeremy DeLuca, were each charged with misdemeanor counts of introduction and delivery of misbranded drugs for interstate commerce. DeLuca will have to pay a personal fine of $600,000 on top of the company's settled payout.

Charges against the company and DeLuca stem from a two year investigation into the company's practices that ended in a federal raid of its headquarters and a Boise, ID warehouse in its possession. At the warehouse, federal agents discovered five different products that were labeled as dietary supplements but actually contained anabolic steroids or synthetic clones. In addition to the fines the company has paid, Bodybuilding.com has been placed on four years of probation, and DeLuca will be on probation for an unspecified period of time.

Fitness supplements often contain dangerous additives, many of which are passed off as natural enhancements. Unfortunately, many of these so-called natural additives are actually potentially dangerous substances, like the anabolic steroids deceptively distributed by Bodybuilding.com. If you or a loved one has been injured by a health or fitness supplement that was mislabeled or contained dangerous additives, you may be entitled to compensation and a dangersous drug attorney can help. Contact a personal injury attorney from Arnold & Itkin today for a free consultation regarding your case.

Categories: Dangerous Drugs
Johnson & Johnson Pulls Vaginal Mesh off the Market
Johnson & Johnson's Ethicon unit told a federal judge on June 4 that it plans to stop selling four different types of vaginal mesh implants&md... Read More [+]
Two More Drugs from NECC Being Investigated for Contamination
The New England Compounding Center (NECC) has been in the public eye since September 2012, when a rare fungal form of meningitis was linked to steroid... Read More [+]
Pharmaceutical Company Withheld Safety Information on Diabetes Drug
A document newly published by the Food and Drug Administration (FDA) reveals that Amylin, the pharmaceutical company which manufactures diabetes drugs... Read More [+]